FDA Investigator Sriram Susrambraham
Sriram Susrambraham has inspections in 1 countries as of 28 Mar 2022. Sriram Susrambraham has collaborated with a combined 365 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
28 Mar 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Canada
Co-Investigator(s):
Alan P Kurtzberg,
Barbara Janine Breithaupt,
Bonita S Chester,
Carla A Norris,
Charles M Edwards,
Dana M Klimavicz,
Edwin Martinez,
Eric S Weilage,
Jeffrey P Raimondi,
Martin K Yan, PhD,
Martin Yan,
Muralidhara B Gavini, PhD,
Nilufer M Tampal, PhD,
Nilufer M Tampalm, PhD,
Raymond T Oji,
Rebecca Rodriguez,
Sarah Forney,
Susan F Laska, MS,
Truong Xuan Nguyen (Andy)
Sriram Susrambraham's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2002 | EIR | Neopharm Labs Inc. - EIR, 2003-01-17 |
November, 2002 | FDA 483 | Neopharm Labs Inc. - Form 483, 2002-11-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more